Anat Loewenstein, MD, Professor of Ophthalmology, Vice Dean of the Faculty of Medicine, and Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at the Tel Aviv University, and the Chairman of the Division of Ophthalmology at the Tel Aviv Medical Center, President of the Israeli Ophthalmological Society.
Main field of interest is the investigation of the drug administration and toxicity to the retina, early detection of macular degeneration and home monitoring of disease. Involved in the development of multiple innovative efforts, was the leader behind the development of novel technology for early detection of macular degeneration, the development of automated technology for detection of retinal disease activity and the development of augmented virtual reality to replace the operating microscope as well as development of home OCT.
Published 435 papers in peer reviewed journals, and contributed multiple chapters to ophthalmology textbooks.
Has multiple roles in the most prominent retina societies. Today, serves on the International committee of the macula society and is currently the General Secretary of the Euretina.
Is active at most international retina meetings and is an invited speaker in most.
Serves as the Editor in Chief of the Journal Case Reports in Ophthalmology, is an associate editor of the European Journal of Ophthalmology and of Ophthalmologica.
Received multiple international awards, ss a leader in retina disease diagnosis and management and serves on the medical advisory boards of most prominent ophthalmological pharma and device companies.
Has many roles as a leader in mentorship of young retina specialists including a mentorship educational program of ARVO, Euretina as well as mentorship programs supported by industry.